title: [Comparison of a safety evaluation between paclitaxel injection NK and Taxol®].
abstract: Paclitaxel injection NK(NK)is a generic product containing the same amount of ingredients as a Taxol®Injection. We examined the safety of NK in clinical practice compared to the original drug. Our results suggested that for the cancer patient, most safety profiles between NK and the original drug are similar. However, patients who received Taxol®Injection had significantly more grade 2 neuropathy compared to those who received NK(p<0. 01).
authors.affiliation: Dept. of Surgery, Kansai Medical University.
authors.forename: Daigo
authors.initials: D
authors.lastname: Yamamoto
authors.forename: Yu
authors.initials: Y
authors.lastname: Tsubota
authors.forename: Noriko
authors.initials: N
authors.lastname: Sueoka
authors.forename: Takashi
authors.initials: T
authors.lastname: Yokoi
authors.forename: Kentaro
authors.initials: K
authors.lastname: Inoue
authors.forename: Masumi
authors.initials: M
authors.lastname: Ohira
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Muranaka
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D017239:Paclitaxel / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel